Novartis Ag (NVS) Other Non-Current Assets (2011 - 2026)
Novartis Ag (NVS) recorded Other Assets of $700 million in Q3 2026, down 85.4% from $4.78 billion a year earlier and down 88.2% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Other Non-Current Assets (2011 - 2026) Analysis & Trends
At the end of FY2025, Novartis Ag reported Other Assets of $5.28 billion, up 50.5% from FY2024.
- Annual Other Assets has increased for three straight years, with a five-year compound annual growth rate of 42.7% (FY2020 to FY2025).
- Across earlier years, Other Assets came in at $3.51 billion in FY2024 (+192.3%), $1.2 billion in FY2023 (+8.0%), $1.11 billion in FY2022 (-49.8%) and $2.21 billion in FY2021 (+147.8%).
- The Q3 2026 figure is the lowest quarterly Other Assets since Q3 2019.
- On a year-over-year basis, Other Assets rose in seven of the last eight quarters, with growth averaging 108.2%.
- Peak year-over-year performance for Other Assets in the last five years was growth of 244.3% in Q3 2025, against a decline of 85.4% in Q3 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $5.93 billion (Q2 2026), $4.98 billion (Q1 2026) and $5.28 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 7.70 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 9.42 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 19.90 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 700.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.60 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.90 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 10.02 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 1.31 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 700.00 Mn |
| Jun 30, 2026 | 5.93 Bn |
| Mar 31, 2026 | 4.98 Bn |
| Dec 31, 2025 | 5.28 Bn |
| Sep 30, 2025 | 4.78 Bn |
| Jun 30, 2025 | 4.47 Bn |
| Mar 31, 2025 | 4.11 Bn |
| Dec 31, 2024 | 3.51 Bn |
| Sep 30, 2024 | 1.39 Bn |
| Jun 30, 2024 | 1.66 Bn |
| Mar 31, 2024 | 1.21 Bn |
| Dec 31, 2023 | 1.20 Bn |
| Sep 30, 2023 | 1.11 Bn |
| Jun 30, 2023 | 1.21 Bn |
| Mar 31, 2023 | 1.21 Bn |
| Dec 31, 2022 | 1.11 Bn |
| Sep 30, 2022 | 3.19 Bn |
| Jun 30, 2022 | 3.89 Bn |
| Mar 31, 2022 | 3.86 Bn |
| Dec 31, 2021 | 2.21 Bn |
API Access
Novartis Ag Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();